Fresh analysis indicates that patients who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise regimens.
Published data in a major health publication points out that while obese individuals can lose about a fifth of their body weight while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"People using such medications should be aware of the potential of fast rebound weight gain when the therapy ends," cautioned expert Dr. Susan Jebb.
That rate of recovery implies a return to starting weight within about one and a half years.
Comparing Treatments
The analysis, which reviewed 37 of trials involving thousands of participants, contrasted the results of GLP-1 agonists with other pills.
The team point out that individuals who shed pounds through dieting generally have a slower creep back—perhaps 0.1 kg a month—post-intervention.
Understanding the Fast Rebound
Doctors suggest the way of the drugs is key to understanding the heightened weight return.
GLP-1 drugs imitate a natural hormone called GLP-1, which moderates feelings of fullness.
"Artificially providing the hormone levels several times higher than normal may cause the system to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' results in appetite is no longer kept in check, making overeating a significant risk."
A Chronic Condition?
Health authorities suggest the injections for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, considering the significant potential of relapse, the treatment is often long-term.
This perspective is supported by pharmaceutical companies, who say that the findings "highlight the long-term nature of excess weight," similar to managing diseases like high blood pressure.
User Experiences
Users who have come off the medication describe a intense return of hunger.
"It felt as if a trigger flipping and you're instantly extremely hungry," recalled one woman.
This difficulty is worsened if users have not adopted permanent dietary or behavioural changes during treatment.
Growing Interest
Figures indicate that millions of people in the UK have used weight-loss jabs in the past year, with interest being substantial.
- Adoption is greater among women than men.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
Ultimately, experts caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a standalone cure and maintained weight loss relies on ongoing lifestyle management.
